Druggable host gene dependencies in primary effusion lymphoma

Area of Science:

• Oncology
• Virology
• Molecular Biology
• Genetics

Background:

• Kaposi's sarcoma-associated herpesvirus (KSHV) is a significant cause of primary effusion lymphoma (PEL).
• Understanding human gene essentiality in PEL is crucial for identifying therapeutic targets.
• Previous studies have identified some gene dependencies, but an updated comprehensive list is needed.

Purpose of the Study:

• To review and update the list of human gene dependencies in PEL-derived cell lines.
• To identify PEL-specific gene dependencies based on improved definitions of core essential genes.
• To explore the potential of these genetic dependencies for therapeutic interventions.

Main Methods:

• Review of existing literature on human gene essentiality in PEL cell lines.
• Analysis of core essential genes across various human cancer types.
• Experimental confirmation of specific gene requirements in PEL cells.

Main Results:

• Identified key gene dependencies in PEL cells, including IRF4, BATF, CCND2, CFLAR, MCL1, and MDM2.
• Demonstrated that KSHV utilizes IRF4 and BATF to drive superenhancer-mediated expression of IRF4, MYC, and CCND2.
• Found shared gene dependencies (IRF4, CCND2, CFLAR) between PEL, Epstein-Barr virus-transformed lymphoblastoid cell lines (LCLs), and adult T-cell leukemia/lymphoma (ATLL) cell lines, alongside distinct dependencies.

Conclusions:

• Human gene essentiality profiling reveals critical dependencies in PEL cells.
• KSHV manipulates host transcription factors (IRF4, BATF) to control gene expression and maintain PEL.
• Identified genetic dependencies offer potential therapeutic strategies for PEL and other related cancers.